Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

As Opioid REMS Meeting Nears, FDA Notes Worry About Shifting Use To Different Class

Dec 03 2009

• By The Pink Sheet Daily

Related Content

Opioid REMS Pilot Program Urged At Public Meeting

May 27 2009

Reopening Of Public Comment Period For Opioid Class REMS Confirms Long Road Ahead

Oct 16 2009

FDA Kicks Off Opioid Class REMS Discussion; Asks For Industry Collaboration

Mar 09 2009

REMS For Opioids Still Has A Long Road Ahead; Advisory Committee Is Likely

Jun 08 2009

REMS For Opioids: Industry Considering Prescriber, Dispenser Certification

May 28 2009

Opioid REMS Should Go Further And Focus On Drug Diversion, Consultants Say

May 28 2009

Pain Market Draws New NDA Submissions

Dec 03 2009

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window